IP Library Patent Application 12235969
Patent Application
App. No. 12/235,969

METHODS AND COMPOSITIONS FOR DIAGNOSING OR MONITORING AUTOIMMUNE AND CHRONIC INFLAMMATORY DISEASES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/235,969
Abstract

Methods of diagnosing or monitoring an autoimmune or chronic inflammatory disease, particularly SLE in a patient by detecting the expression level of one or more genes or surrogates derived therefrom in the patient are described. Diagnostic oligonucleotides for diagnosing or monitoring chronic inflammatory disease, particularly SLE infection and kits or systems containing the same are also described.

Claims (8)

1 . A method of diagnosing or monitoring an autoimmune or chronic inflammatory disease in a patient, comprising detecting the expression level of a nucleic acid in said patient to diagnose or monitor said autoimmune or chronic inflammatory disease in said patient wherein said nucleic acid comprises the nucleotide sequence SEQ ID NO: 694.

2 . The method of claim 1 wherein said autoimmune or chronic inflammatory disease is systemic lupus erythematosis (SLE).

3 . The method of claim 1 wherein said expression level is detected by measuring the RNA level expressed by said nucleic acid.

4 . The method of claim 3 , further comprising isolating RNA from said patient prior to detecting said RNA level expressed by said nucleic acid.

5 . The method of claim 3 wherein said RNA level is detected by PCR.

6 . The method of claim 3 wherein said RNA level is detected by hybridization.

7 . The method of claim 3 wherein said RNA level is detected by hybridization to an oligonucleotide.

8 . The method of claim 7 wherein said oligonucleotide comprises DNA, RNA, cDNA, PNA, genomic DNA, or synthetic oligonucleotides.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Aug 17, 2012
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
To: XDX, INC.
Reel/Frame 028805/0922 →
RELEASE OF SECURITY INTEREST Recorded Aug 9, 2012
From: LEADER VENTURES, LLC
To: XDX, INC.
Reel/Frame 028757/0096 →
SECURITY AGREEMENT Recorded Mar 31, 2011
From: XDX, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 026066/0125 →
RELEASE OF SECURITY INTEREST Recorded Jan 20, 2011
From: TRIPLEPOINT CAPITAL LLC
To: XDX, INC.
Reel/Frame 025671/0583 →
SECURITY AGREEMENT Recorded Aug 31, 2009
From: XDX, INC.
To: LEADER VENTURES, LLC, AS AGENT
Reel/Frame 023163/0695 →
SECURITY AGREEMENT Recorded Aug 31, 2009
From: XDX, INC.
To: TRIPLEPOINT CAPITAL LLC
Reel/Frame 023163/0704 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2009
From: WOHLGEMUTH, JAY; FRY, KIRK; WOODWARD, ROBERT; LY, NGOC
To: XDX, INC.
Reel/Frame 022967/0696 →